These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3778943)

  • 41. Demonstration of a diurnal variation in serum parathyroid hormone in primary and secondary hyperparathyroidism.
    Sinha TK; Miller S; Feming J; Khairi R; Edmondson J; Johnston CC; Bell NH
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1009-13. PubMed ID: 1239461
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunological evidences for the presence of small late carboxylterminal fragment(s) of human parathyroid hormone (PTH) in circulation in man.
    D'Amour P; Labelle F; Wolde-Giorghis R; Hamel L
    J Immunoassay; 1989; 10(2-3):191-205. PubMed ID: 2745718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of synthetic human parathyroid hormone 1-34 in man measured by cytochemical bioassay and radioimmunoassay.
    Kent GN; Loveridge N; Reeve J; Zanelli JM
    Clin Sci (Lond); 1985 Feb; 68(2):171-7. PubMed ID: 3967464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bioactivity of parathyroid hormone and parathyroid hormone-like peptide: agonist and antagonist activities of amino-terminal fragments as assessed by the cytochemical bioassay and in situ biochemistry.
    Loveridge N; Dean V; Goltzman D; Hendy GN
    Endocrinology; 1991 Apr; 128(4):1938-46. PubMed ID: 2004612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Normal parathyroid hormone responsiveness of bone-derived cells from a patient with pseudohypoparathyroidism.
    Ish-Shalom S; Rao LG; Levine MA; Fraser D; Kooh SW; Josse RG; McBroom R; Wong MM; Murray TM
    J Bone Miner Res; 1996 Jan; 11(1):8-14. PubMed ID: 8770691
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patients.
    Hackeng WH; Lips P; Netelenbos JC; Lips CJ
    J Clin Endocrinol Metab; 1986 Aug; 63(2):447-53. PubMed ID: 3088025
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of parathyroid hormone bioactivity by human parathyroid hormone (PTH)-(3-84) and PTH-(8-84) synthesized in Escherichia coli.
    Born W; Loveridge N; Petermann JB; Kronenberg HM; Potts JT; Fischer JA
    Endocrinology; 1988 Oct; 123(4):1848-53. PubMed ID: 3046927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current Nomenclature of Pseudohypoparathyroidism: Inactivating Parathyroid Hormone/Parathyroid Hormone-Related Protein Signaling Disorder.
    Turan S
    J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):58-68. PubMed ID: 29280743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of endogenous and exogenous parathyroid hormone on tubular reabsorption of calcium in pseudohypoparathyroidism.
    Yamamoto M; Takuwa Y; Masuko S; Ogata E
    J Clin Endocrinol Metab; 1988 Mar; 66(3):618-25. PubMed ID: 2832440
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PTH bioactivity in osteoporosis.
    Saphier PW; Stamp TC; Kelsey CR; Loveridge N
    Bone Miner; 1987 Oct; 3(1):75-83. PubMed ID: 3505195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Homozygous [Cys25]PTH(1-84) Mutation That Impairs PTH/PTHrP Receptor Activation Defines a Novel Form of Hypoparathyroidism.
    Lee S; Mannstadt M; Guo J; Kim SM; Yi HS; Khatri A; Dean T; Okazaki M; Gardella TJ; Jüppner H
    J Bone Miner Res; 2015 Oct; 30(10):1803-13. PubMed ID: 25891861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pseudohypoparathyroidism 1b: exclusion of parathyroid hormone and its receptors as candidate disease genes.
    Jan de Beur SM; Ding CL; LaBuda MC; Usdin TB; Levine MA
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2239-46. PubMed ID: 10852457
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Kidney and osseous responsiveness to PTH in a case of pseudohypoparathyroidism (author's transl)].
    Quesada JM; Guerrero J; Hervás F; Vázquez C
    An Esp Pediatr; 1981 Mar; 14(3):183-8. PubMed ID: 6267973
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phenotypic and molecular genetic aspects of pseudohypoparathyroidism type Ib in a Greek kindred: evidence for enhanced uric acid excretion due to parathyroid hormone resistance.
    Laspa E; Bastepe M; Jüppner H; Tsatsoulis A
    J Clin Endocrinol Metab; 2004 Dec; 89(12):5942-7. PubMed ID: 15579741
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective uptake of intact parathyroid hormone by the liver: differences between hepatic and renal uptake.
    Martin K; Hruska K; Greenwalt A; Klahr S; Slatopolsky E
    J Clin Invest; 1976 Oct; 58(4):781-8. PubMed ID: 965485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Difference in the therapeutic response to active vitamin D3 between PTH-deficient hypoparathyroidism and pseudohypoparathyroidism].
    Inoue D
    Clin Calcium; 2007 Aug; 17(8):1255-61. PubMed ID: 17660624
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Malignancy-associated hypercalcemia: evaluation with a cytochemical bioassay for parathyroid hormone.
    Goltzman D; Stewart AF; Broadus AE
    J Clin Endocrinol Metab; 1981 Nov; 53(5):899-904. PubMed ID: 6270184
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pseudohypoparathyroidism with osteitis fibrosa cystica: direct demonstration of skeletal responsiveness to parathyroid hormone in cells cultured from bone.
    Murray TM; Rao LG; Wong MM; Waddell JP; McBroom R; Tam CS; Rosen F; Levine MA
    J Bone Miner Res; 1993 Jan; 8(1):83-91. PubMed ID: 8427051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Plasma 1.25 (OH)2D and PTH levels and urinary cyclic AMP response to exogenous PTH in PHP during childhood (author's transl)].
    Seino Y; Ishida M; Shimotsuji J; Ishii T; Matsuda S
    Horumon To Rinsho; 1979 Aug; 27(8):879-84. PubMed ID: 226296
    [No Abstract]   [Full Text] [Related]  

  • 60. Failure of tooth eruption and brachydactyly in pseudohypoparathyroidism are not related to plasma parathyroid hormone-related protein levels.
    Reis MT; Matias DT; Faria ME; Martin RM
    Bone; 2016 Apr; 85():138-41. PubMed ID: 26855372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.